Elinor Mertz, the Chief Financial Officer of $ABNB, sold 6,250 shares of the company on 06-04-2025 for an estimated $826,750. We received data on the trade from a recent SEC filing. This was a sale of approximately 1.3% of their shares of this class of stock. Following this trade, they now own 467,611 shares of this class of $ABNB stock.
$ABNB Insider Trading Activity
$ABNB insiders have traded $ABNB stock on the open market 138 times in the past 6 months. Of those trades, 0 have been purchases and 138 have been sales.
Here’s a breakdown of recent trading of $ABNB stock by insiders over the last 6 months:
- JOSEPH GEBBIA has made 0 purchases and 63 sales selling 2,809,929 shares for an estimated $360,140,114.
- BRIAN CHESKY (CEO and Chairman) has made 0 purchases and 41 sales selling 815,692 shares for an estimated $119,003,801.
- NATHAN BLECHARCZYK (Chief Strategy Officer) has made 0 purchases and 4 sales selling 214,189 shares for an estimated $33,443,491.
- ELINOR MERTZ (Chief Financial Officer) has made 0 purchases and 9 sales selling 73,395 shares for an estimated $10,372,997.
- ARISTOTLE N BALOGH (Chief Technology Officer) has made 0 purchases and 20 sales selling 44,863 shares for an estimated $6,188,776.
- DAVID C BERNSTEIN (Chief Accounting Officer) sold 1,000 shares for an estimated $137,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$ABNB Hedge Fund Activity
We have seen 652 institutional investors add shares of $ABNB stock to their portfolio, and 592 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HARRIS ASSOCIATES L P added 4,598,125 shares (+86.0%) to their portfolio in Q1 2025, for an estimated $549,292,012
- JENNISON ASSOCIATES LLC removed 3,219,864 shares (-32.1%) from their portfolio in Q1 2025, for an estimated $384,644,953
- PACER ADVISORS, INC. added 2,685,026 shares (+2297.4%) to their portfolio in Q1 2025, for an estimated $320,753,205
- FARALLON CAPITAL MANAGEMENT LLC removed 2,429,200 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $290,192,232
- MORGAN STANLEY removed 2,025,536 shares (-13.0%) from their portfolio in Q1 2025, for an estimated $241,970,530
- AQR CAPITAL MANAGEMENT LLC added 1,916,676 shares (+81.0%) to their portfolio in Q1 2025, for an estimated $228,966,114
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 1,812,579 shares (-94.9%) from their portfolio in Q1 2025, for an estimated $216,530,687
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$ABNB Congressional Stock Trading
Members of Congress have traded $ABNB stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $ABNB stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN has traded it 2 times. They made 1 purchase worth up to $15,000 on 02/25 and 1 sale worth up to $15,000 on 04/08.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 01/24.
- REPRESENTATIVE WILLIAM R. KEATING sold up to $15,000 on 01/07.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$ABNB Analyst Ratings
Wall Street analysts have issued reports on $ABNB in the last several months. We have seen 0 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Underweight" rating on 04/16/2025
To track analyst ratings and price targets for $ABNB, check out Quiver Quantitative's $ABNB forecast page.
$ABNB Price Targets
Multiple analysts have issued price targets for $ABNB recently. We have seen 3 analysts offer price targets for $ABNB in the last 6 months, with a median target of $143.0.
Here are some recent targets:
- An analyst from Canaccord Genuity set a target price of $180.0 on 04/28/2025
- Deepak Mathivanan from Cantor Fitzgerald set a target price of $101.0 on 04/16/2025
- Stephen Ju from UBS set a target price of $143.0 on 02/04/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
